Bio-Rad Laboratories ROE 2010-2023 | BIO.B
Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO.B) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Bio-Rad Laboratories ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-03-31 |
$-0.19B |
$9.76B |
-2.08% |
| 2022-12-31 |
$-3.63B |
$9.62B |
-39.03% |
| 2022-09-30 |
$-6.02B |
$8.45B |
-58.41% |
| 2022-06-30 |
$-1.93B |
$8.92B |
-16.05% |
| 2022-03-31 |
$-0.09B |
$10.18B |
-0.71% |
| 2021-12-31 |
$4.25B |
$13.69B |
33.22% |
| 2021-09-30 |
$6.67B |
$15.33B |
56.23% |
| 2021-06-30 |
$4.05B |
$11.60B |
39.63% |
| 2021-03-31 |
$4.11B |
$10.61B |
44.78% |
| 2020-12-31 |
$3.81B |
$9.88B |
47.16% |
| 2020-09-30 |
$3.52B |
$8.83B |
49.88% |
| 2020-06-30 |
$1.95B |
$7.35B |
31.73% |
| 2020-03-31 |
$1.58B |
$6.29B |
27.87% |
| 2019-12-31 |
$1.76B |
$5.76B |
33.11% |
| 2019-09-30 |
$0.38B |
$5.13B |
7.71% |
| 2019-06-30 |
$0.90B |
$5.49B |
18.76% |
| 2019-03-31 |
$0.57B |
$4.86B |
12.44% |
| 2018-12-31 |
$0.37B |
$4.02B |
8.09% |
| 2018-09-30 |
$1.28B |
$4.90B |
30.12% |
| 2018-06-30 |
$1.03B |
$4.64B |
27.64% |
| 2018-03-31 |
$0.77B |
$4.49B |
23.46% |
| 2017-12-31 |
$0.12B |
$2.93B |
4.32% |
| 2017-09-30 |
$0.02B |
$2.85B |
0.58% |
| 2017-06-30 |
$0.01B |
$2.81B |
0.44% |
| 2017-03-31 |
$0.03B |
$2.71B |
0.94% |
| 2016-12-31 |
$0.03B |
$2.58B |
0.96% |
| 2016-09-30 |
$0.09B |
$2.70B |
3.63% |
| 2016-06-30 |
$0.09B |
$2.62B |
3.69% |
| 2016-03-31 |
$0.10B |
$2.54B |
4.19% |
| 2015-12-31 |
$0.11B |
$2.49B |
4.60% |
| 2015-09-30 |
$0.10B |
$2.43B |
4.45% |
| 2015-06-30 |
$0.10B |
$2.36B |
4.35% |
| 2015-03-31 |
$0.10B |
$2.20B |
4.59% |
| 2014-12-31 |
$0.09B |
$2.19B |
4.07% |
| 2014-09-30 |
$0.08B |
$2.18B |
3.66% |
| 2014-06-30 |
$0.06B |
$2.25B |
2.82% |
| 2014-03-31 |
$0.07B |
$2.23B |
3.02% |
| 2013-12-31 |
$0.08B |
$2.19B |
3.71% |
| 2013-09-30 |
$0.09B |
$2.12B |
4.42% |
| 2013-06-30 |
$0.14B |
$2.07B |
7.00% |
| 2013-03-31 |
$0.15B |
$2.03B |
7.86% |
| 2012-12-31 |
$0.17B |
$2.02B |
8.64% |
| 2012-09-30 |
$0.18B |
$1.94B |
9.88% |
| 2012-06-30 |
$0.19B |
$1.85B |
10.38% |
| 2012-03-31 |
$0.18B |
$1.84B |
10.11% |
| 2011-12-31 |
$0.18B |
$1.74B |
10.57% |
| 2011-09-30 |
$0.19B |
$1.69B |
11.38% |
| 2011-06-30 |
$0.19B |
$1.73B |
11.79% |
| 2011-03-31 |
$0.18B |
$1.61B |
12.51% |
| 2010-12-31 |
$0.19B |
$1.54B |
13.35% |
| 2010-09-30 |
$0.16B |
$1.43B |
11.75% |
| 2010-06-30 |
$0.15B |
$1.30B |
11.74% |
| 2010-03-31 |
$0.15B |
$1.30B |
12.16% |
| 2009-12-31 |
$0.15B |
$1.28B |
12.36% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.071B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
